Clinical Manifestations and Laboratory Tests of AECHB and Severe Hepatitis (Liver Failure)
Liver failure is defined as serious damage to the liver cause by a variety of etiologies, leading to liver function disorder or even decompensation, and clinical syndromes with coagulopathy, jaundice, hepatic encephalopathy, and ascites.
Severe hepatitis B can be indicated pathologically by apparent hepatocellular necrosis, including extensive multifocal, confluent, bridging, sub-massive or massive necrosis.
Laboratory tests during the course of severe exacerbation of chronic hepatitis B can reflect pathological changes and liver function in a timely manner, providing objective and informative reference data for evaluation of disease severity and treatment efficacy. Among the most important laboratory tests are those for prothrombin activity, international normalized ratio, and increases in total bilirubin concentration.
Severe hepatitis B is associated with interactions between the virus and host factors. Detection of HBV DNA, HBV genotype, quasispecies and HBV mutation can provide important theoretical bases for the prevention, control or mitigation of the progress of severe hepatitis B.
Noninvasive imaging modalities can be used to visualize the entire liver and parts of it. Measuring liver volume to evaluate liver size and liver reserve capacity is regarded as important in diagnosis, surgical approach and prognostic evaluation of patients with severe exacerbation of chronic hepatitis B and liver failure.
Model for End-Stage Liver Disease (MELD) is the first quantitative method developed to assess whether a patient with liver failure requires a liver transplant. The predictive value of the MELD model has been improved by the MELD-Na, iMELD, and MESO models. Several other valuable prognostic models have been developed. For example, for patients with HBV-ACLF, the established TPPM scoring system was found to be more predictive than MELD score.
- 1.Gan Z, Bing Z, Za Z. Diagnostic and treatment guidelines for liver failure. Chinese J Hepatol. 2006;14(9):643–6. (Article in Chinese)Google Scholar
- 29.Torresi J, Earnest-Silveira L, Civitico G, et al. Restoration of replication phenotype of lamivudine-resistant hepatitis B virus mutants by compensatory changes in the “fingers” subdomain of the viral polymerase selected as a consequence of mutations in the overlapping S gene. Virology. 2002;299(1):88–99.PubMedCrossRefGoogle Scholar
- 61.Kubo KS, Stuart RM, Freitas-Astúa J, Antonioli-Luizon R, Locali-Fabris EC, Coletta-Filho HD, Machado MA, Kitajima EW. Evaluation of the genetic variability of orchid fleck virus by single-strand conformational polymorphism analysis and nucleotide sequencing of a fragment from the nucleocapsid gene. Arch Virol. 2009;154(6):1009–14.PubMedPubMedCentralCrossRefGoogle Scholar
- 71.Cai CJ, Lu MQ, editors. Peri-operative therapies of patients receiving liver transplantation due to severe hepatitis. Guangzhou, China: Sun Yat-sen University Press; 2008. ISBN: 9787306031860Google Scholar
- 72.Liu TH, Zhu JY, Zhang SQ, et al. Establishment of a scoring system for evaluating the severity of hepatitis B patients with acute-on-chronic liver failure. Chin J Infect Dis. 2010;28(5):293–6.Google Scholar